Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104316216 | 10431621 | 6 | F | 20130506 | 20160721 | 20140904 | 20160725 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-40812BP | BOEHRINGER INGELHEIM | 78.74 | YR | F | Y | 100.00000 | KG | 20160725 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104316216 | 10431621 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 150 MG | 22512 | 75 | MG | CAPSULE | BID | ||||||
104316216 | 10431621 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 150 MG | 22512 | 75 | MG | CAPSULE | BID | ||||||
104316216 | 10431621 | 3 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 150 MG | 22512 | 75 | MG | CAPSULE | BID | ||||||
104316216 | 10431621 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG | 0 | 325 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 5 | C | ZESTRIL | LISINOPRIL | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 6 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 200 MG | 0 | 100 | MG | CAPSULE | BID | ||||||
104316216 | 10431621 | 7 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 0 | |||||||||||
104316216 | 10431621 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG | 0 | 20 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 10 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | DOSE PER APPLICATION: 750MG/150ML | 0 | ||||||||||
104316216 | 10431621 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 650 MG | 0 | 325 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 12 | C | LASIX | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 40 MG IN 4 ML VIAL | 0 | 40 | MG | ||||||||
104316216 | 10431621 | 13 | C | PROVENTIL | ALBUTEROL | 1 | Respiratory (inhalation) | 0.5%, 2.5 MG/0.5 ML, NEBULIZATION | 0 | 2.5 | MG | ||||||||
104316216 | 10431621 | 14 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 0.02%, 0.5 MG/2.5 ML, NEBULIZATION | 0 | .5 | MG | ||||||||
104316216 | 10431621 | 15 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | DOSE PER APPLICATION AND DAILY DOSE: 100 UNITS/ML FLEXPEN | 0 | QD | |||||||||
104316216 | 10431621 | 16 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 30 MG | 0 | 30 | MG | QD | |||||||
104316216 | 10431621 | 17 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 2 MG | 0 | 2 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 18 | C | ZYLOPRIM | ALLOPURINOL | 1 | Oral | 200 MG | 0 | 100 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 19 | C | LUMIGAN | BIMATOPROST | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 0.03% OP SOLUTION 100 DROPS/5 ML | 0 | ORAL DROPS | QD | ||||||||
104316216 | 10431621 | 20 | C | COREG | CARVEDILOL | 1 | Oral | 12.5 MG | 0 | 6.25 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 21 | C | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 ANZ | 0 | BID | |||||||||
104316216 | 10431621 | 22 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | .05 | MG | TABLET | ||||||||
104316216 | 10431621 | 23 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 24 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 25 | C | SENOKOT | SENNOSIDES | 1 | Oral | 17.2 MG | 0 | 17.2 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 26 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG | 0 | 25 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 27 | C | MYCOSTATIN | NYSTATIN | 1 | Oral | 2000000 U | 0 | 500000 | IU | ORAL SUSPENSION | Q6H | ||||||
104316216 | 10431621 | 28 | C | PERI COLACE | 2 | Oral | STRENGTH: 50/8.6 MG, DAILY DOSE: 1 TABLET DAILY AS NEEDED | 0 | TABLET | ||||||||||
104316216 | 10431621 | 29 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | STRENGTH: 5/325 MG, DAILY DOSE: 1 TABLET 3 TIMES DAILY AS NEEDED | 0 | TABLET | |||||||||
104316216 | 10431621 | 30 | C | ROBITUSSIN (GUAIFENESIN) | GUAIFENESIN | 1 | Oral | FORMULATION: LIQUID, STRENGTH: 200 MG/10ML, DAILY DOSE: 100 MG ORALLY EVERY 6 HOURS AS NEEDED | 0 | 100 | MG | ||||||||
104316216 | 10431621 | 31 | C | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | STRENGTH: 20000 UNITS/1 ML | 0 | 10000 | IU | ||||||||
104316216 | 10431621 | 32 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 7142.8571 U | 0 | 50000 | IU | CAPSULE | |||||||
104316216 | 10431621 | 33 | C | FERAHEME | FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE | 1 | Intravenous (not otherwise specified) | STRENGTH: 510 MG/17 ML VIAL | 0 | 510 | MG | ||||||||
104316216 | 10431621 | 34 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 80 MG | 0 | 40 | MG | BID | |||||||
104316216 | 10431621 | 35 | C | IPRATROPIUM | IPRATROPIUM | 1 | Respiratory (inhalation) | 3 MG | 0 | .5 | MG | Q4H | |||||||
104316216 | 10431621 | 36 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 15 MG | 0 | 2.5 | MG | Q4H | |||||||
104316216 | 10431621 | 37 | C | FLUTICASONE/SALMETEROL | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 ANZ | 0 | Q12H | |||||||||
104316216 | 10431621 | 38 | C | XOPENEX CONCENTRATE | 2 | Respiratory (inhalation) | STRENGTH: 1.25 MG/0.5 ML NEBULIZATION | 0 | 1.25 | MG | |||||||||
104316216 | 10431621 | 39 | C | IRON | IRON | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
104316216 | 10431621 | 40 | C | INSULIN | INSULIN NOS | 1 | Unknown | 0 | |||||||||||
104316216 | 10431621 | 41 | C | INSULIN | INSULIN NOS | 1 | Intravenous (not otherwise specified) | 0 | 10 | IU | |||||||||
104316216 | 10431621 | 42 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | |||||||||||
104316216 | 10431621 | 43 | C | LASIX | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
104316216 | 10431621 | 44 | C | CALCIUM GLUCONATE. | CALCIUM GLUCONATE | 1 | Unknown | STRENGTH: 2 DOSES | 0 | ||||||||||
104316216 | 10431621 | 45 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | 5 | IU | |||||||||
104316216 | 10431621 | 46 | C | INSULIN ASPART | INSULIN ASPART | 1 | Subcutaneous | 0 | Q6H | ||||||||||
104316216 | 10431621 | 47 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Unknown | 0.05 MCG/KG/MIN | 0 | 16 | MG | ||||||||
104316216 | 10431621 | 48 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 49 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 50 | C | SALMETEROL XINAFOATE | SALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 100 MCG | 0 | 50 | UG | Q12H | |||||||
104316216 | 10431621 | 51 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 500 MCG | 0 | 250 | UG | Q12H | |||||||
104316216 | 10431621 | 52 | C | CHLORPHENIRAMINE POLISTIREX | 2 | Oral | 16 MG | 0 | 8 | MG | ORAL SUSPENSION | BID | |||||||
104316216 | 10431621 | 53 | C | CHLORPHENIRAMINEHYDROCODONE | CHLORPHENIRAMINEHYDROCODONE | 1 | Oral | 20 MG | 0 | 10 | MG | ORAL SUSPENSION | BID | ||||||
104316216 | 10431621 | 54 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 15 MG | 0 | 15 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 55 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | 0 | 4 | MG | TABLET | ||||||||
104316216 | 10431621 | 56 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 0 | 250 | MG | TABLET | ||||||||
104316216 | 10431621 | 57 | C | CIPROFLOXACIN HCL | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 1000 MG | 0 | 500 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 58 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 1300 MG | 0 | 325 | MG | TABLET | Q6H | ||||||
104316216 | 10431621 | 59 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 30 MG | 0 | 7.5 | MG | TABLET | Q6H | ||||||
104316216 | 10431621 | 60 | C | AMOXICILLIN TRI | 2 | Oral | 1750 MG | 0 | 875 | MG | TABLET | BID | |||||||
104316216 | 10431621 | 61 | C | POTASSIUM CLAV | 2 | Oral | 250 MG | 0 | 125 | MG | TABLET | BID | |||||||
104316216 | 10431621 | 62 | C | TELMISARTAN. | TELMISARTAN | 1 | Oral | 80 MG | 0 | 80 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 63 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | DAILY DOSE: ONE HALF TABLET EVERY NIGHT AT BEDTIME AS NEEDED | 0 | 5 | MG | TABLET | |||||||
104316216 | 10431621 | 64 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 80 MG | 0 | 80 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 65 | C | INSULIN DETEMIR | INSULIN DETEMIR | 1 | Subcutaneous | INJECTION; STRENGTH: 100U/ML; DAILY DOSE: 8 UNITS EVERY MORNING AND 24 UNITS EVERY NIGHT | 0 | ORAL SOLUTION | |||||||||
104316216 | 10431621 | 66 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 60 MEQ | 0 | 30 | MEQ | TABLET | BID | ||||||
104316216 | 10431621 | 67 | C | EPOETIN ALPHA | 2 | Other | 1428.5714 U | 0 | 10000 | IU | ORAL SOLUTION | /wk | |||||||
104316216 | 10431621 | 68 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG | 0 | 1 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 69 | C | NYSTATIN. | NYSTATIN | 1 | Oral | STRENGTH: 100 KU/ML, DAILY DOSE: 400KU/ML | 0 | ORAL SUSPENSION | QID | ||||||||
104316216 | 10431621 | 70 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 71 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Topical | 1:1 | 0 | CREAM | BID | ||||||||
104316216 | 10431621 | 72 | C | HYDROXYZINE HCL | HYDROXYZINE HYDROCHLORIDE | 1 | Oral | 150 MG | 0 | 50 | MG | TABLET | TID | ||||||
104316216 | 10431621 | 73 | C | FLUVIRIN NOS | INFLUENZA VIRUS VACCINE | 1 | Intramuscular | STRENGTH: 45MCG/.5ML; 0.5ML SYRINGE | 0 | ||||||||||
104316216 | 10431621 | 74 | C | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | Oral | DOSE PER APPLICATION: 0.12 %; DAILY DOSE: ONE-HALF OUNCE TWICE DAILY | 0 | ORAL SOLUTION | BID | ||||||||
104316216 | 10431621 | 75 | C | ROSIGLITAZONE MALEATE. | ROSIGLITAZONE MALEATE | 1 | Oral | 8 MG | 0 | 8 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 76 | C | TRIAMTERENE. | TRIAMTERENE | 1 | Oral | 75 MG | 0 | 75 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 77 | C | HYDROCHLOROTHIAZID | HYDROCHLOROTHIAZIDE | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 78 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Unknown | STRENGTH: 0.1% DAILY DOSE: 0.1% TWICE DAILY | 0 | CREAM | BID | ||||||||
104316216 | 10431621 | 79 | C | GLYBURIDE MICRONIZED | 2 | Oral | 0 | 6 | MG | TABLET | |||||||||
104316216 | 10431621 | 80 | C | LUMIGAN | BIMATOPROST | 1 | Oral | STRENGTH: 0.03%; ROUTE: OPHTHALMIC | 0 | ORAL DROPS | |||||||||
104316216 | 10431621 | 81 | C | ALLERGAN | PAPAIN | 1 | Unknown | 0 | 2.5 | ML | ORAL DROPS | ||||||||
104316216 | 10431621 | 82 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 60 MG | 0 | 30 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 83 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 2000 MG | 0 | 1000 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 84 | C | CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | CHLORPHENIRAMINE MALEATEPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | Unknown | 2 ANZ | 0 | CAPSULE | BID | ||||||||
104316216 | 10431621 | 85 | C | ACIPHEX | RABEPRAZOLE SODIUM | 1 | Unknown | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 86 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 87 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 88 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 3.125 | MG | TABLET | ||||||||
104316216 | 10431621 | 89 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG | 0 | 10 | MG | QD | |||||||
104316216 | 10431621 | 90 | C | PEPCID | FAMOTIDINE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 91 | C | PEPCID | FAMOTIDINE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 92 | C | LUMIGAN | BIMATOPROST | 1 | Unknown | 0 | |||||||||||
104316216 | 10431621 | 93 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 50 MCG | 0 | 50 | UG | QD | |||||||
104316216 | 10431621 | 94 | C | GUAIFENESIN. | GUAIFENESIN | 1 | Oral | 1200 MG | 0 | 600 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 95 | C | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | Oral | 180 ML | 0 | 30 | ML | ORAL SUSPENSION | Q4H | ||||||
104316216 | 10431621 | 96 | C | NITROSTAT | NITROGLYCERIN | 1 | Unknown | 115.2 MG | 0 | .4 | MG | ||||||||
104316216 | 10431621 | 97 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 0 | INHALATION POWDER, HARD CAPSULE | QD | |||||||||
104316216 | 10431621 | 98 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 325 MG | 0 | 325 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 99 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 MCG | 0 | 1000 | UG | TABLET | QD | ||||||
104316216 | 10431621 | 100 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG | 0 | 500 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 101 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Oral | 600 MG | 0 | 300 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 102 | C | ZAROXOLYN | METOLAZONE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
104316216 | 10431621 | 103 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG | 0 | .5 | MG | TABLET | BID | ||||||
104316216 | 10431621 | 104 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 50 MCG | 0 | 50 | UG | TABLET | QD | ||||||
104316216 | 10431621 | 105 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 1200 MG | 0 | 600 | MG | TABLET | Q12H | ||||||
104316216 | 10431621 | 106 | C | MICARDIS HCT | HYDROCHLOROTHIAZIDETELMISARTAN | 1 | Oral | 1 TABLET, 80-25MG | 0 | TABLET | QD | ||||||||
104316216 | 10431621 | 107 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 200 MG | 0 | 100 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104316216 | 10431621 | 1 | Anticoagulant therapy |
104316216 | 10431621 | 4 | Product used for unknown indication |
104316216 | 10431621 | 5 | Product used for unknown indication |
104316216 | 10431621 | 6 | Product used for unknown indication |
104316216 | 10431621 | 7 | Product used for unknown indication |
104316216 | 10431621 | 8 | Product used for unknown indication |
104316216 | 10431621 | 9 | Product used for unknown indication |
104316216 | 10431621 | 10 | Product used for unknown indication |
104316216 | 10431621 | 11 | Pyrexia |
104316216 | 10431621 | 12 | Product used for unknown indication |
104316216 | 10431621 | 13 | Product used for unknown indication |
104316216 | 10431621 | 14 | Product used for unknown indication |
104316216 | 10431621 | 15 | Type 2 diabetes mellitus |
104316216 | 10431621 | 16 | Product used for unknown indication |
104316216 | 10431621 | 17 | Product used for unknown indication |
104316216 | 10431621 | 18 | Product used for unknown indication |
104316216 | 10431621 | 19 | Product used for unknown indication |
104316216 | 10431621 | 20 | Product used for unknown indication |
104316216 | 10431621 | 21 | Product used for unknown indication |
104316216 | 10431621 | 22 | Product used for unknown indication |
104316216 | 10431621 | 23 | Product used for unknown indication |
104316216 | 10431621 | 24 | Product used for unknown indication |
104316216 | 10431621 | 25 | Product used for unknown indication |
104316216 | 10431621 | 26 | Product used for unknown indication |
104316216 | 10431621 | 27 | Product used for unknown indication |
104316216 | 10431621 | 28 | Constipation |
104316216 | 10431621 | 29 | Pain |
104316216 | 10431621 | 30 | Cough |
104316216 | 10431621 | 31 | Product used for unknown indication |
104316216 | 10431621 | 32 | Product used for unknown indication |
104316216 | 10431621 | 33 | Product used for unknown indication |
104316216 | 10431621 | 34 | Product used for unknown indication |
104316216 | 10431621 | 35 | Product used for unknown indication |
104316216 | 10431621 | 36 | Product used for unknown indication |
104316216 | 10431621 | 37 | Product used for unknown indication |
104316216 | 10431621 | 38 | Product used for unknown indication |
104316216 | 10431621 | 39 | Iron deficiency |
104316216 | 10431621 | 40 | Type 2 diabetes mellitus |
104316216 | 10431621 | 41 | Hyperkalaemia |
104316216 | 10431621 | 42 | Hyperkalaemia |
104316216 | 10431621 | 43 | Acute respiratory failure |
104316216 | 10431621 | 44 | Hyperkalaemia |
104316216 | 10431621 | 45 | Type 2 diabetes mellitus |
104316216 | 10431621 | 46 | Diabetes mellitus |
104316216 | 10431621 | 47 | Product used for unknown indication |
104316216 | 10431621 | 48 | Product used for unknown indication |
104316216 | 10431621 | 49 | Product used for unknown indication |
104316216 | 10431621 | 50 | Product used for unknown indication |
104316216 | 10431621 | 51 | Product used for unknown indication |
104316216 | 10431621 | 52 | Product used for unknown indication |
104316216 | 10431621 | 53 | Product used for unknown indication |
104316216 | 10431621 | 54 | Product used for unknown indication |
104316216 | 10431621 | 55 | Product used for unknown indication |
104316216 | 10431621 | 56 | Product used for unknown indication |
104316216 | 10431621 | 57 | Product used for unknown indication |
104316216 | 10431621 | 58 | Product used for unknown indication |
104316216 | 10431621 | 59 | Product used for unknown indication |
104316216 | 10431621 | 60 | Product used for unknown indication |
104316216 | 10431621 | 61 | Product used for unknown indication |
104316216 | 10431621 | 62 | Product used for unknown indication |
104316216 | 10431621 | 63 | Product used for unknown indication |
104316216 | 10431621 | 64 | Product used for unknown indication |
104316216 | 10431621 | 65 | Product used for unknown indication |
104316216 | 10431621 | 66 | Product used for unknown indication |
104316216 | 10431621 | 67 | Product used for unknown indication |
104316216 | 10431621 | 68 | Product used for unknown indication |
104316216 | 10431621 | 69 | Product used for unknown indication |
104316216 | 10431621 | 70 | Product used for unknown indication |
104316216 | 10431621 | 71 | Product used for unknown indication |
104316216 | 10431621 | 72 | Product used for unknown indication |
104316216 | 10431621 | 73 | Product used for unknown indication |
104316216 | 10431621 | 74 | Product used for unknown indication |
104316216 | 10431621 | 75 | Product used for unknown indication |
104316216 | 10431621 | 76 | Product used for unknown indication |
104316216 | 10431621 | 77 | Product used for unknown indication |
104316216 | 10431621 | 78 | Product used for unknown indication |
104316216 | 10431621 | 79 | Product used for unknown indication |
104316216 | 10431621 | 80 | Product used for unknown indication |
104316216 | 10431621 | 81 | Product used for unknown indication |
104316216 | 10431621 | 82 | Product used for unknown indication |
104316216 | 10431621 | 83 | Product used for unknown indication |
104316216 | 10431621 | 84 | Product used for unknown indication |
104316216 | 10431621 | 85 | Product used for unknown indication |
104316216 | 10431621 | 86 | Product used for unknown indication |
104316216 | 10431621 | 87 | Product used for unknown indication |
104316216 | 10431621 | 88 | Product used for unknown indication |
104316216 | 10431621 | 89 | Product used for unknown indication |
104316216 | 10431621 | 90 | Product used for unknown indication |
104316216 | 10431621 | 92 | Product used for unknown indication |
104316216 | 10431621 | 93 | Product used for unknown indication |
104316216 | 10431621 | 94 | Product used for unknown indication |
104316216 | 10431621 | 95 | Product used for unknown indication |
104316216 | 10431621 | 96 | Chest pain |
104316216 | 10431621 | 97 | Product used for unknown indication |
104316216 | 10431621 | 98 | Product used for unknown indication |
104316216 | 10431621 | 99 | Product used for unknown indication |
104316216 | 10431621 | 100 | Product used for unknown indication |
104316216 | 10431621 | 101 | Product used for unknown indication |
104316216 | 10431621 | 102 | Product used for unknown indication |
104316216 | 10431621 | 103 | Product used for unknown indication |
104316216 | 10431621 | 104 | Product used for unknown indication |
104316216 | 10431621 | 105 | Pulmonary congestion |
104316216 | 10431621 | 106 | Product used for unknown indication |
104316216 | 10431621 | 107 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104316216 | 10431621 | HO |
104316216 | 10431621 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104316216 | 10431621 | Acute kidney injury | |
104316216 | 10431621 | Cardiogenic shock | |
104316216 | 10431621 | Gastrointestinal haemorrhage | |
104316216 | 10431621 | Haemorrhagic anaemia | |
104316216 | 10431621 | Respiratory failure | |
104316216 | 10431621 | Shock haemorrhagic |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104316216 | 10431621 | 1 | 201203 | 0 | ||
104316216 | 10431621 | 2 | 201304 | 20130430 | 0 | |
104316216 | 10431621 | 3 | 20130506 | 0 | ||
104316216 | 10431621 | 4 | 20120808 | 0 | ||
104316216 | 10431621 | 5 | 20120811 | 0 | ||
104316216 | 10431621 | 8 | 20120808 | 0 | ||
104316216 | 10431621 | 9 | 20120808 | 0 | ||
104316216 | 10431621 | 10 | 20120807 | 0 | ||
104316216 | 10431621 | 11 | 20120808 | 0 | ||
104316216 | 10431621 | 12 | 20120808 | 0 | ||
104316216 | 10431621 | 13 | 20120808 | 0 | ||
104316216 | 10431621 | 14 | 20120808 | 0 | ||
104316216 | 10431621 | 16 | 20120808 | 0 | ||
104316216 | 10431621 | 17 | 20120808 | 0 | ||
104316216 | 10431621 | 18 | 20120808 | 0 | ||
104316216 | 10431621 | 20 | 20120808 | 0 | ||
104316216 | 10431621 | 21 | 20120808 | 0 | ||
104316216 | 10431621 | 22 | 20120808 | 0 | ||
104316216 | 10431621 | 23 | 20120808 | 0 | ||
104316216 | 10431621 | 24 | 20120808 | 0 | ||
104316216 | 10431621 | 25 | 20120808 | 0 | ||
104316216 | 10431621 | 26 | 20120808 | 0 | ||
104316216 | 10431621 | 27 | 20120808 | 0 | ||
104316216 | 10431621 | 28 | 20120808 | 0 | ||
104316216 | 10431621 | 29 | 20120808 | 0 | ||
104316216 | 10431621 | 30 | 20120811 | 0 | ||
104316216 | 10431621 | 31 | 20120811 | 0 | ||
104316216 | 10431621 | 32 | 20120812 | 0 | ||
104316216 | 10431621 | 33 | 20120812 | 0 | ||
104316216 | 10431621 | 34 | 20130501 | 0 | ||
104316216 | 10431621 | 35 | 20130501 | 0 | ||
104316216 | 10431621 | 36 | 20130501 | 0 | ||
104316216 | 10431621 | 37 | 20130502 | 0 | ||
104316216 | 10431621 | 38 | 20120703 | 0 | ||
104316216 | 10431621 | 45 | 20130506 | 0 | ||
104316216 | 10431621 | 46 | 20130507 | 0 | ||
104316216 | 10431621 | 90 | 20120405 | 0 | ||
104316216 | 10431621 | 94 | 20120404 | 0 | ||
104316216 | 10431621 | 95 | 20120404 | 0 | ||
104316216 | 10431621 | 96 | 20120404 | 0 | ||
104316216 | 10431621 | 97 | 20120405 | 0 | ||
104316216 | 10431621 | 98 | 20120405 | 0 | ||
104316216 | 10431621 | 99 | 20120405 | 0 | ||
104316216 | 10431621 | 100 | 20120414 | 0 | ||
104316216 | 10431621 | 101 | 20120413 | 0 | ||
104316216 | 10431621 | 102 | 20120413 | 0 | ||
104316216 | 10431621 | 103 | 20120409 | 0 | ||
104316216 | 10431621 | 107 | 20120404 | 0 |